EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in Cryptosporidium parvum and HCT-8 Host Cells

Jubilee Ajiboye, Anne-Christine Uldry iD, Manfred Heller iD, Arunasalam Naguleswaran iD, Erkang Fan, Wesley C Van Voorhis iD, Andrew Hemphill iD, Joachim Müller iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25052707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jubilee Ajiboye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Parasitology, Vetsuisse Faculty, University of Bern, Länggass-Strasse 122, 3012 Bern, Switzerland. Hauptthemen laut MEDLINE: Cryptosporidium parvum, Cryptosporidiosis, Cryptosporidium, Antiprotozoal Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cryptosporidium parvum is an apicomplexan parasite causing persistent diarrhea in humans and animals. Issuing from target-based drug development, calcium-dependent protein kinase 1 inhibitors, collectively named bumped kinase inhibitors (BKIs), with excellent efficacies in vitro and in vivo have been generated. Some BKIs including BKI-1748 share a core structure with similarities to the first-generation antiprotozoal drug quinine, which is known to exert notorious side effects. Unlike quinine, BKI-1748 rapidly interfered with C. parvum proliferation in the human colon tumor (HCT) cell line HCT-8 cells and caused dramatic effects on the parasite ultrastructure. To identify putative BKI targets in C. parvum and in host cells, we performed differential affinity chromatography with cell-free extracts from non-infected and infected HCT-8 cells using BKI-1748 and quinine epoxy-activated sepharose columns followed by mass spectrometry. C. parvum proteins of interest were identified in eluates from columns coupled to BKI-1748, or in eluates from both BKI-1748 and quinine columns. However, no C. parvum proteins could be identified binding exclusively to BKI-1748. In contrast, 25 BKI-1748-specific binding proteins originating from HCT-8 cells were detected. Moreover, 29 C. parvum and 224 host cell proteins were identified in both BKI-1748 as well as in quinine eluates. In both C. parvum and host cells, the largest subset of binding proteins was involved in RNA binding and modification, with a focus on ribosomal proteins and proteins involved in RNA splicing. These findings extend previous results, showing that BKI-1748 interacts with putative targets involved in common, essential pathways such as translation and RNA processing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cryptosporidium parvumCryptosporidiosisCryptosporidiumAntiprotozoal AgentsAntineoplastic AgentsAnimalsHumansQuinine

Stichwörter der Autor:innen

affinity chromatographybinding proteinsproteomicsside effectssplicing

Substanzen

QuinineAntiprotozoal AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • Institute of Parasitology, Vetsuisse Faculty, University of Bern, Länggass-Strasse 122, 3012 Bern, Switzerland.
  • Cellular, Molecular and Biomedical Sciences Graduate Program, University of Vermont, Burlington, VT 05405, USA.
  • Proteomics and Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Bern, Länggass-Strasse 122, 3012 Bern, Switzerland.
  • Institute of Molecular Pathology, Vetsuisse Faculty, University of Bern, Länggass-Strasse 122, 3012 Bern, Switzerland.
  • Department of Biochemistry, University of Washington, Seattle, WA 98109, USA.
  • Center for Emerging and Re-Emerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA.

ORCID-Profile: Anne-Christine Uldry, Manfred Heller, Arunasalam Naguleswaran, Wesley C Van Voorhis, Andrew Hemphill, Joachim Müller

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • NICHD NIH HHS
  • Swiss National Science Foundation
  • National Institutes of Health NIH
  • US USDA/NIFA
  • National Institutes of Allergy and Infectious Diseases NIAID

Zitieren

APA

Ajiboye, J., Uldry, A. C., Heller, M., Naguleswaran, A., Fan, E., Van Voorhis, W. C., Hemphill, A., & Müller, J. (2024). Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in Cryptosporidium parvum and HCT-8 Host Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052707

Vancouver

Ajiboye J, Uldry AC, Heller M, Naguleswaran A, Fan E, Van Voorhis WC, et al. Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in Cryptosporidium parvum and HCT-8 Host Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052707

BibTeX
@article{Ajiboye2024,
  author = {Ajiboye, Jubilee and Uldry, Anne-Christine and Heller, Manfred and Naguleswaran, Arunasalam and Fan, Erkang and Van Voorhis, Wesley C and Hemphill, Andrew and Müller, Joachim},
  title = {Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in Cryptosporidium parvum and HCT-8 Host Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25052707}
}
Kostenlos starten →